The upregulation of VCAM-1 on colorectal tumour tissues compared to normal colonic tissues implies the potential utility of anti-VCAM-1 antibodies for visualising not only sites of colitis but also malignant polyps and neoplastic lesions during CRC. Here, VCAM1 is linked to colorectal carcinoma.